Rabbit Recombinant Monoclonal CXCL2 antibody. Suitable for IP, WB and reacts with Rat samples. Cited in 4 publications.
View Alternative Names
Cinc3, Mip-2, Mip2, Scyb2, Cxcl2, C-X-C motif chemokine 2, Cytokine-induced neutrophil chemoattractant 3, Macrophage inflammatory protein 2, CINC-3, MIP2
- IP
Unknown
Immunoprecipitation - Anti-CXCL2 antibody [EPR23331-159] (AB275879)
This data was developed using ab275879, the same antibody clone in a different buffer formulation.
CXCL2 was immunoprecipitated from 0.35 mg Rat lung organ treated with 10 ug/ml Concanavalin A for 3 days culture supernatant 10 µl with ab275879 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab275879 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Rat lung organ treated with 10 ug/ml Concanavalin A for 3 days culture supernatant 10 µl
Lane 2 : ab275879 IP in Rat lung organ treated with 10 ug/ml Concanavalin A for 3 days culture supernatant
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab275879 in rat lung organ treated with 10 ug/ml Concanavalin A for 3 days culture supernatant
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 32 seconds
This blot was developed using a higher sensitivity ECL substrate.
false
- WB
Lab
Western blot - Anti-CXCL2 antibody [EPR23331-159] (AB275879)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time : 15 seconds.
All lanes:
Western blot - Anti-CXCL2 antibody [EPR23331-159] (ab275879) at 1/1000 dilution
Lane 1:
Untreated rat lung organ culture, supernatant at 10 µL
Lane 2:
Rat lung organ (treated with 10/ml Concanavalin A for 3 days) culture, supernatant at 10 µL
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 11 kDa
Observed band size: 10 kDa
false
- WB
Lab
Western blot - Anti-CXCL2 antibody [EPR23331-159] (AB275879)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time : 6 seconds.
All lanes:
Western blot - Anti-CXCL2 antibody [EPR23331-159] (ab275879) at 1/1000 dilution
All lanes:
Recombinant Rat CXCL2 protein, 10 ng
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 11 kDa
Observed band size: 10 kDa
false
Related conjugates and formulations (1)
-
Anti-CXCL2 antibody [EPR23331-159] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCL2 attracts and activates neutrophils as part of the innate immune response. It acts independently not as part of a larger complex to provoke a chemotactic response guiding neutrophils to areas of tissue injury. CXCL2 also promotes the release of other cytokines and enzymes that contribute to inflammation. Its activity is mediated through its interaction with receptors like CXCR2 on target cell surfaces.
Pathways
CXCL2 is involved in inflammatory signaling and leukocyte migration. It holds importance in the chemokine signaling pathway which regulates leukocyte trafficking. CXCL2 interacts with proteins like CXCR2 influencing the inflammation process by activating downstream kinases and other signal transduction molecules such as mitogen-activated protein kinases (MAPKs).
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2304722 PubMed37870186
2023
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e15305 PubMed37101626
2023
Applications
Unspecified application
Species
Unspecified reactive species
Inflammopharmacology 30:2345-2357 PubMed36131109
2022
Applications
Unspecified application
Species
Unspecified reactive species
International heart journal 63:755-762 PubMed35831147
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com